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Summary
Aging leads to dysregulation of multiple components of the
immune system that results in increased susceptibility to infec-
tions and poor response to vaccines in the aging population. The
dysfunctions of adaptive B and T cells are well documented, but
the effect of aging on innate immunity remains incompletely
understood. Using a heterogeneous population of peripheral
blood mononuclear cells (PBMCs), we first undertook transcrip-
tional profiling and found that PBMCs isolated from old individ-
uals (≥ 65 years) exhibited a delayed and altered response
to stimulation with TLR4, TLR7/8, and RIG-I agonists compared
to cells obtained from adults (≤ 40 years). This delayed response
to innate immune agonists resulted in the reduced production of
pro-inflammatory and antiviral cytokines and chemokines includ-
ing TNFa, IL-6, IL-1b, IFNa, IFNc, CCL2, and CCL7. While the major
monocyte and dendritic cell subsets did not change numerically
with aging, activation of specific cell types was altered. PBMCs
from old subjects also had a lower frequency of CD40+ mono-
cytes, impaired up-regulation of PD-L1 on monocytes and T cells,
and increased expression of PD-L2 and B7-H4 on B cells. The
defective immune response to innate agonists adversely affected
adaptive immunity as TLR-stimulated PBMCs (minus CD3 T cells)
from old subjects elicited significantly lower levels of adult T-cell
proliferation than those from adult subjects in an allogeneic
mixed lymphocyte reaction (MLR). Collectively, these age-associ-
ated changes in cytokine, chemokine and interferon production,
as well as co-stimulatory protein expression could contribute to
the blunted memory B- and T-cell immune responses to vaccines
and infections.
Key words: immunosenescence; innate immune agonists;
innate immunity; interferon signaling; pattern recognition
receptors; peripheral blood mononuclear cells.
Introduction
In the United States, the number of individuals over age 65 is estimated
to increase to 20% of the total population by the year 2040 (Kinsella &
Wan, 2009). Aging has been linked to increased susceptibility to many
infectious diseases including influenza, West Nile virus (WNV), and
bacterial pneumonia (Gavazzi & Krause, 2002). Unfortunately, many
vaccines used in preventive strategies (e.g., seasonal influenza vaccine)
do not induce an effective immune response in the elderly when
compared to younger adults due to age-related dysfunctions in
immunity, termed immunosenescence (Katz et al., 2004). Studies to
understand the basis of immunosenescence and to enhance protective
immunity in older adults are necessary to improve the health outcome
for this expanding segment of the population.
An efficient immune response to invading pathogens or vaccination
requires intricate interactions between innate and adaptive immune
cells. Innate immune cells via pattern recognition receptors (PRRs) initiate
and support adaptive immunity through virtue of their functions
including phagocytosis, intracellular killing, release of pro-inflammatory
and antiviral cytokines and chemokines, as well as antigen presentation
and immune cell priming. The effect of ‘normal’ human aging on innate
and adaptive immunity has been a challenge to define. Published data
on the age-associated alterations in adaptive immunity have demon-
strated a shift from naive to a memory T-cell phenotype, decreased T-cell
responses to stimulation in vitro, oligoclonal expansion in the T- and B-
cell repertoire, and reduced germinal center antigen responses (Nikolich-
Zugich, 2008; Linterman, 2014). Aging has also been shown to influence
the expression of multiple co-stimulatory and inhibitory molecules and
their ligands on T and B cells and antigen-presenting cells, including
CD80 expression on monocytes and ICOS and CTLA-4 expression on T
cells (Leng et al., 2002; van Duin et al., 2007a; Canaday et al., 2013).
The impact of aging on innate immunity is less well understood
particularly in humans. Aging has been linked to shift in absolute
numbers of innate immune cells (including monocytes, DCs, and NK
cells), impaired recruitment of these cells to site of infection, reduced
phagocytosis by monocytes/macrophages, as well as altered production
of interferons, chemokines, and cytokines, and altered Toll-like receptor
(TLR) expression (Gomez et al., 2005; Panda et al., 2009; Solana et al.,
2012). These alterations suggest possible age-related dysfunction in PRRs
responses; however, no clear consensus has been reached in defining
age-related innate immune defects, in part due to the difficulty to
extrapolate between mouse and human studies, the use of individual cell
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populations for analysis, and different age-related enrollment criteria
used for subject selection.
In this report, we applied a comprehensive approach to evaluate the
effects of a broad range of innate immune agonists on PBMCs isolated
from healthy nonfrail adults (21–40 years) and old (65–93 years)
subjects. Peripheral blood mononuclear cells (PBMCs) were used because
they are composed of monocytes, dendritic cells, and lymphocytes
(including T, B, and NK cells) and as a composite group represent a key
defense against infection. Using PBMCs, we assessed the impact of
aging on PRR signaling in heterogeneous population simulating the
intracellular and intercellular interactions under physiological conditions.
Besides treatment of PBMCs with specific PRR agonists, we enumerated
DC and monocyte subsets, examined surface expression of co-stimula-
tory molecules by flow cytometry, analyzed transcriptome data, and
measured cytokine and chemokine production in cultured supernatants.
This approach allowed us to identify deficiencies in the PRR response in
PBMCs from elderly subjects. Our findings represent a comprehensive
analysis of the influence of human aging on PRR signaling/function and
have implications for strategies to enhance the immune response in the
context of infection or immunization.
Results
Individual PRR agonists elicited distinct transcriptional
responses
To evaluate the transcriptional profiles elicited by individuals’ innate
agonists on the integrity of human PRR signaling, PBMCs were isolated
from healthy nonfrail adults and old donors (n = 8/group). Individuals
with comorbid conditions including cancer (within the last 5 years for
those ≥ 65 years), immunocompromising disorders and steroid usage
(see Table 1) were excluded, whereas inclusion criteria included
controlled hypertension, occasional/tolerable ‘aching joints’ from arthri-
tis and not taking daily NSAIDS or acetaminophen, and controlled
diabetes (see experimental procedures). For a description of the cohort
from which these individuals were selected, see Table S7. Cells were
stimulated for 6 and 24 hours (h) with LPS (TLR4), CLO97 (TLR7/8), poly
I:C complexed with Lyovec (MDA-5/RIGI), or 50-pppRNA complexed with
Lyovec (RIG-I) (see experimental procedures), and the scope of PRR
responses to innate agonist stimulation was evaluated by microarray
analysis using Illumina BeadChips (see experimental procedures). Tran-
scriptional profiles were generated by comparing LPS and CLO97-
stimulated PBMCs to untreated PBMCs, whereas 50-pppRNA/Lyovec and
poly I:C/Lyovec-stimulated PBMCs were compared to Lyovec (a cationic
transfection reagent that optimizes 50-pppRNA and poly I:C effects by
facilitating intracellular delivery)-only treated PBMCs. Differentially
expressed genes (DEGs) were selected based on false discovery rate
(FDR) 5% and fold change (FC) ≥ 1.3 or ≤ 1.3. These criteria were
chosen based on our own validation scheme used for other published
studies (Gaucher et al., 2008; Goulet et al., 2013).
The use of sixteen subjects (n = 8/group) for gene array analysis was
sufficient as it yielded discriminating gene expression profiles with high
number of DEGs with stringent P values. The number of DEGs was
higher for LPS, CLO97, and 50-pppRNA/Lyovec when compared to poly I:
C/Lyovec (Fig. 1A). The FDR, FC, and P value of all DEGs resulting from
stimulation for each agonist are listed in Table S1 (adult) and S2 (old).
Differentially expressed genes in response to each agonist steadily
increased through 24 h in both age groups. At 24 h, higher numbers of
DEGs were observed in response to 50-pppRNA/Lyovec in adults when
compared to old individuals (1828 vs. 1176), whereas the number of
DEGs was higher in response to LPS in old relative to adult individuals
(3410 vs. 1335). Similar number of DEGs was observed in response to
CLO97 (1268 vs. 1037) and poly I:C/Lyovec (447 vs. 439) in both age
groups.
Single-gene analysis shows unique age-related differences in
innate immune responses to PRR agonists
We determined whether aging impacted the immune response to
agonists by comparing the transcriptional profiles of adult and old
individuals. We focused our analysis on innate immunity using an
immune gene filter (containing over 4000 genes) derived from Gene
Ontology (GO:0045087) (Ashburner et al., 2000; Carbon et al., 2009).
We first compared the untreated response of PBMCs from adult and old
individuals at 6 h to determine whether there was an intrinsic difference
independent of stimulation. We observed a marginal difference in
untreated gene expression with only 71 genes differentially expressed at
higher levels in PBMCs from adults relative to old individuals (data not
shown). And only 16 of these transcripts (HERC5, IFIT1/2, IRAK3, ISG15,
MX1, OAS2/3, DHX58, SLAMF7, CCL2, CCL22, IFITM1/2/3, and IL10RB)
were annotated as immune response-related genes using the DAVID
functional genomic database (da Huang et al., 2009). These small
differences in the expression of immune genes suggest that observed
differences between adult and old subjects were due primarily to their
response to agonist stimulation.
Using a Venn diagram analysis, we examined the unique and
common responses elicited by LPS, CLO97, 50-pppRNA/Lyovec, and poly
I:C/Lyovec for both age groups (Fig. 1B). We compared transcriptional
profiles (normalized to negative controls) of adult to old subjects, and
using the innate immune gene filter, we identified unique immune-
related DEGs for each age group (Fig. 1B). Table S3 lists the unique and
common DEGs resulting from Venn diagram analysis of adults to old
Table 1 Description of subjects used for gene array, cytokine analysis, and surface
phenotypic analysis
Adult (n = 8) Old (n = 8)
Average age (range) 29 (22–38) 73 (66–85)
Gender M/F (female %) 4/4 (50%) 4/4 (50%)
Race
White (non-Hispanics) 1 7
White (Hispanics) 4
African American 1 1
Others (non-Hispanics) 2
Comorbidities 3 (38%) 5 (63%)
None 5 (63%) 3 (38%)
Hypothyroid 1




Over the counter 0 (0%) 1 (12.5%)
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individuals. At 6 h, relative to old individuals, PBMCs from adults appear
uniquely to induce transcriptional signatures associated with pro-
inflammatory chemokines and antiviral mediators that promote activa-
tion and trafficking of immune cells, including IFNc and IL23A elicited by
LPS; IFNc, CXCL2, CXCL9, IL27, and IL17RD elicited by CLO97; and
CXCL10, CCL8, and IFNb1 elicited by 50-pppRNA/Lyovec. At 24 h,
PBMCs from adults stimulated with LPS and CLO97 continued to
upregulate IFNc; similarly, poly I:C/Lyovec stimulation uniquely elicited
IFNa2 and IFNb1 only in samples from adult but not old individuals.
Moreover, cells from old subjects showed upregulation of unique
cytokine transcripts including CCL1, CCL22, CCR7, IL4, IL5RA, and IL9R
for LPS; IL1A, CCL1, CCL7, CCR7, and CCL22 for CLO97; and IL15RA,
IFNa10, and IFNa7 for 50-pppRNA/Lyovec; and CXCL11, IL10, IL17RD,
and IL1b for poly I:C/Lyovec (Fig. 1B and Table S3). Overall, adult
subjects displayed higher and sustained expression levels of multiple
interferon (IFN) genes as well as unique expression of effector cytokine
and chemokine genes.
Pathway analysis reveals an age-related delay in immune
responses to PRR agonists
To gain a deeper insight into age-related changes in immune gene
expression, we performed a pathway-based analysis using ingenuity
pathway analysis (IPA). We evaluated whether expression of disparate
canonical pathways was induced in PBMCs from adult and old
individuals. We determined significant enrichment of a particular
pathway by calculating the numbers of genes in that pathway that
were differentially expressed (P value < 0.05 and FC ≥ 1.3 or ≤ 1.3) in
response to a particular stimulus compared to untreated or Lyovec-
treated only PBMCs. Pathway enrichment scores indicate the percentage
of DEGs in a specific pathway (for example, 0.15 indicates 15% of genes
were differentially expressed). The pathway heat map shows the
enrichment scores of immune-related pathways selected from the top
forty functional pathways (Fig. 2). Table S4 lists the pathway enrichment
scores, P values, and enriched genes for each agonist.
(A)
(B)
Fig. 1 Single-gene analysis shows unique
age-related differences in immune
responses to PRR agonists. Agonist-treated
cells (LPS, CLO97, poly I:C/Lyovec, or 50-
pppRNA/Lyovec) from adult and old
subjects (n = 8/group) were normalized to
their respective negative controls
(untreated or Lyovec only treated). Gene
array analysis was performed using an
Illumina platform, and differentially
expressed genes (DEGs) were selected to
have a FDR 5% with FC ≥ 1.3 or ≤ 1.3.
(A) Histograms depict the kinetics of
expression and number of DEGs for
agonist-treated adult and old subjects for 6
and 24 h. (B) Venn diagram analysis of
agonist-treated adult (A) compared to
treated old (O) subjects at 6 (top row) and
24 h (bottom row). Diagrams show the
number of unique and common statistically
significant genes based on the above
criteria. Listed above and below each
diagram are cytokines and chemokines that
are uniquely elicited by each agonist at 6
and 24 h, respectively. Upregulated and
downregulated genes in respect to negative
controls are depicted by up- and downward
arrows, respectively.
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Overall, LPS and CLO97 stimulated the largest number of enriched
pathways in both adult and old subjects, whereas interferon signaling
was the highest enriched functional pathway for all tested agonists in
both age groups (Fig. 2A). We observed a higher enrichment of the
IFN signaling pathway following 6 h stimulation with 50-pppRNA of
PBMCs from adults (44% P < 0.001) when compared to those from
old individuals (19.4% P < 0.05) (Fig. 2B). This reflected a delay in IFN
responses in old individuals, because there was no difference in
enrichment 24 h poststimulation (adult 50% vs. old 47.2%) (Fig. 2B).
The induction of the role of JAK1, JAK2, and TYK2 in interferon
signaling pathway also was delayed in PBMCs from old compared to
adult individuals following stimulation with 50-pppRNA/Lyovec at 6 h
(11.1% P < 0.05 and 37% P < 0.001, respectively), but not at 24 h
(25.9% and 33.3% enrichment) (Fig. 2B). Other functional pathways
that were more enriched in adults after 6 h stimulation included the
Jak/Stat signaling (28.6% P < 0.001 vs. 18.6% P < 0.01) following
LPS stimulation (Fig. 2B). This pathway was again restored in old
individuals to similar levels to adults after 24 h stimulation (both at
21% enrichment). Similarly, CLO97 stimulation elicited higher enrich-
ment of pathways in adults [including the communication between
innate and adaptive immune cells (29% vs. 18%), IL-10 signaling
(31% vs. 18%), and the role of cytokines in mediating communica-
tion between immune cells (31% vs. 18%)], compared to old
donors at 6 h (Fig. 2B). After 24 h, both age groups showed similar
induction of these pathways further indicating that the old donors
exhibited a delayed immune response to PRR agonists. We observed
no significant enrichment of pathways following stimulation with poly
I:C/Lyovec at 6 h, and at 24 h, we observed similar enrichment of the




Fig. 2 Adults show a faster and greater enrichment of functional pathways relative to old subjects. (A) Transcriptional profiles for adult and old individuals (n = 8/group)
generated by comparing agonist-treated PBMCs (LPS, CLO97, poly I:C/Lyovec, or 50-pppRNA/Lyovec) to negative controls (untreated or Lyovec only treated) were
analyzed by IPA canonical pathway database. Genes undergoing pathway analysis passed nominal P < 0.05 and FC ≥ 1.3 or ≤ 1.3 statistical cutoffs. Heat map depicts
enrichment of a custom selected list of canonical pathways (y-axis) at different contrasts (x-axis). Pathways are considered statistically significant (P < 0.05) if they pass
a threshold score > 0.15 (indicating 15% gene enrichment) based on a Fisher’s test. Scale ranges from blue (pathway not significantly enriched, score < 0.15) to orange
(significantly enriched pathway). (B) Table shows enrichment scores and P values of selected pathways elicited by LPS, CLO97, and 50-pppRNA/Lyovec compared to
negative controls, which shows the delay response at 6 h in old subjects.
Age-related alterations in innate immune responses, T. U. Metcalf et al.424
ª 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Contributions of immune subsets to age-related alterations in
gene expression
Monocytes and dendritic cell express distinct PRRs and produce a range
of pro- and anti-inflammatory cytokines and other mediators. To
evaluate the impact of aging on the numbers and proportion of
monocytes and DCs in the blood, we used flow cytometry staining to
identify three monocyte subsets, (i) classical (CD14+CD16), (ii) pro-
inflammatory (CD14+CD16+), and (iii) nonclassical (CD14dimCD16+), and
three DC subsets, (i) myeloid (m)DC1 (CD11c+CD1c+CD141CD303),
(ii) mDC2 (CD11cloCD1cCD141+CD303), and (iii) plasmacytoid (p)DCs
(CD11cloCD1cCD141CD303+) (Fig. S1). Using the same individuals
used for gene array analysis (n = 8/group), our analysis indicated that the
frequencies and absolute numbers of individual monocyte and DC
subsets did not vary with aging (Fig. S1). In addition, we observed similar
comparison of subsets between age groups when we increased the
number of subjects (data not shown). We performed univariate analysis
to evaluate the effect of gender and ethnicity on absolute number of
monocytes and found no significant effect of these two factors on the
comparable numbers between age groups (data not shown). Therefore,
the delayed and altered innate immune response observed in old
individuals could not be ascribed to a mere change in subset abundance.
Rather, they were likely due to a decreased induction of gene expression
in particular cell subsets.
To assess the contributions of specific cell types in the overall
peripheral blood immune response signature in adult vs. old individ-
uals, we applied an approach for deconvoluting gene expression
profiles based on the meta-analysis of cell type-specific gene
expression signatures from publicly available microarray studies (Na-
kaya et al., 2011). A positive normalized enrichment score (+NES)
represents upregulation in adults, whereas a negative score (NES)
represents upregulation in old subjects (Fig. 3). Table S5 lists
the specific cell type NES, P values, and enriched genes for each
agonist.
After 6 h of LPS, 50-pppRNA/Lyovec, or poly I:C/Lyovec stimulation,
PBMCs from adults induced genes that were preferentially expressed by
monocytes (+NES 2.11, 1.42, and 2.72, respectively), whereas LPS and
poly I:C/Lyovec induced genes specific to T cells (+NES 1.87 and 1.23,
respectively) when compared to cells from older individuals (Fig. 3A). By
24 h of stimulation, PBMCs from adults induced immune genes that
were specific to three cell types: (i) monocytes in response to LPS (+NES
2.06), 50-pppRNA/Lyovec (+NES 1.34), and poly I:C/Lyovec (+NES 1.53),
(ii) T cells in response to LPS (+NES 1.87), and (iii) B cells in response to
CLO97 (+NES 1.24) and 50-pppRNA (+NES 1.28). For PBMCs from old
subjects, gene induction of cellular subsets following stimulation was
observed only after CLO97 treatment at 24 h, which upregulated genes
associated with T cells (NES 1.76), mDCs (NES 1.35), and
monocytes (NES 1.92) (Fig. 3B). Overall, genes corresponding to
monocytes were strongly induced at an early time after PRR agonist
treatment in PBMCs from adult subjects. Moreover, cells from adult
subjects exhibited greater responsiveness within specific cellular subsets
suggesting that aging limits PRR responsiveness in several different cell
types. Importantly, similar frequency of monocytes (Fig. S1) with
comparable expression of TLR3 (mainly recognize naked poly I:C and
to some extent poly I:C complexed with Lyovec), TLR4 (LPS), and TLR7
(CLO97) (Fig. S2) was observed between age groups; thus, the delayed
monocyte response in old individuals was not due to lower TLR
expression.
Age-associated alteration in surface expression of immune
regulatory molecules
To further define the significance of age-related changes after PRR
stimulation, we measured the basal expression levels of key molecules
(A) (B)
Fig. 3 Agonist stimulation induced a monocyte cell signature in adults compared to old counterparts. Transcriptional profiles generated from comparing adult stimulated
PBMCs to old stimulated PBMCs (n = 8/group) were analyzed using cell type-specific modules. The radial plots illustrate the enrichment of genes associated with T and B cells,
natural killer (NK), plasmacytoid (p), and myeloid (m) DCs, and monocyte subsets for a given treatment (LPS, CLO97, poly I:C/Lyovec, or 50-pppRNA/Lyovec) at 6 (A) and 24 h
(B), by plotting the Normalized Enrichment Score (NES) calculated by GSEA that takes into account the FDR using the Benjamini and Hochberg method (Subramanian et al.,
2005). Gene sets induced in a specific cell type that was significantly enriched in adults or old subjects are denoted by asterisks: * for P value < 0.05. A positive enrichment
score (+NES; radially outward from 0) represents upregulation in adults, whereas a negative score (NES; inward from 0 to center) represents upregulation in old subjects.
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(e.g., CTLA-4, PD-L2, and CD40) that regulate immune cell activa-
tion (Fig. 4A). The frequencies of CD14+CD16-CD40+ monocytes
(17.7% vs. 5.9% P < 0.01) and CD40+ B cells (7.5% vs. 4.4%
P < 0.05) were higher in adults compared to old subjects (Fig. 4A and
S3). However, we did not detect a difference in the surface
expression of inhibitory molecules on monocytes (CTLA-4 and PD-L2)
or DCs (PD-L1, PD-L2, and CTLA-4) with aging (Fig. 4A and data not
shown).
The expression of regulatory molecules (including ICOS, CTLA-4, PD-
L1, PD-L2, and B7-H4) on peripheral blood subsets also was examined in
response to TLR7/8 stimulation. For both age groups, PD-L1 was
significantly upregulated on monocytes, T cells, and B cells and PD-L2
was upregulated on monocytes and B cells, whereas B7-H4 was
upregulated only on B cells from old subjects (Fig. 4B). At 24 h, PD-L1
expression was greater on the surface of CD14+ monocytes from adults
(mean fluorescence intensity (MFI) 92 136 vs. 60 073 P < 0.01) and
CD3+ T cells (MFI 560 vs. 374 P < 0.01) compared to old individuals
(Fig. 4B). However, B cells from old subjects had higher expression of
inhibitory molecules PD-L2 (MFI 213 vs. 113 P < 0.01) and B7-H4 (MFI
93 vs. 21 P < 0.01) (Fig. 4B). No difference in expression levels of ICOS
and CTLA-4 was detected on any cell type between adult and old
subjects (data not shown). These results suggest that aging alters the
surface expression of key regulatory molecules on innate and adaptive
immune cells, which could contribute to the dysfunctional immune
response observed in the elderly.
PBMCs from adults produced higher levels of inflammatory
cytokines, IFNs, and chemokines in response to PRR agonists
To assess whether the observed delayed transcriptional immune
response in PBMCs from old individuals translated into lower production
of cytokines and chemokines, we profiled supernatants from PRR-
stimulated PBMCs used in gene array analysis. Supernatants were initially
analyzed by ELISA and cytometric bead array kits (CBA); however, to
gain a more global analysis of multiple cytokine/chemokine production,
supernatants were analyzed using Milliplex bead assays. Table S6 lists
concentrations of measured cytokines and chemokines elicited by each
agonist. At 24 h, we observed the highest induction of cytokines and
chemokines following the stimulation of TLR7/8 including IFNa, IFNc,
TNFa, IL-1b, IL-6, IL-1RA, IL-10, CCL1, CCL2, CCL3, CCL4, CCL7,
CXCL1, CXCL10, CX3CL1, and VEGF. In comparison, TLR4 stimulation
induced secretion of IFNa, TNFa, IL-1a/1b, IL-2, IL-6, IL-13, IL-23, IL-1RA,
IL-10, CCL1, CCL3, CCL4, CCL22, CXCL1, CX3CL1, VEGF, G-CSF, GM-
CSF, and Flt-3L, whereas RIG-I activation induced the expression of IFNa,
(A)
(B)
Fig. 4 Age-related changes in surface
expression of co-stimulatory molecules. (A)
PBMCs were stained for CD3+ T cells,
CD19+ B cells, CD14+ monocytes, and
either CTLA, PD-L2, or CD40. CTLA and PD-
L2 (n = 21/group) and CD40 (n = 12/
group). Individual values along with
mean  SEM are shown. P values were
determined by comparing adult to old
subjects using the Mann–Whitney U-test.
(B) PBMCs isolated from adult and old
subjects (n = 8/group) were stimulated
with CLO97 for 24 h. PBMCs were stained
for CD3+ (T cells), CD19+ (B cells), CD14+
(monocytes), and either PD-L1, PD-L2, or
B7-H4. MFI values along with mean  SEM
are shown. Statistical significance between
adult (A) and old (O) subjects was
determined by two-way ANOVA followed
by Sidak correction for multiple
comparisons. For untreated vs. treated, P
values are not shown for significant
upregulation: PD-L1 on monocytes and B
cells from both age groups (P < 0.001) and
on T cells from A (P < 0.001) and O
(P < 0.01); PD-L2 on monocytes from A
(P < 0.001) and O (P < 0.01) and B cells
from A (P < 0.01) and O (P < 0.001); B7-
H4 on B cells from O (P < 0.05).
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CCL7, CCL8, CXCL5, and CXCL10. Poly I:C stimulation failed to elicit a
measurable cytokine response.
A comparison of adults to old subjects revealed age-related alterna-
tion in the production of IFNa (149 vs. 19 pg mL1 P < 0.01), TNFa (116
vs. 56 pg mL1 P < 0.001), and CCL2 (677 vs. 317 pg mL1 P < 0.001),
which was higher in PBMCs from adults treated with CLO97 for 6 h
(Fig. 5A). IFNa was restored in old subjects by 24 h after stimulation with
CLO97, whereas cells from adults still produced higher levels of TNFa
and CCL2 (Fig. 5A). Our results at 24 h showed PBMCs from adults in
response to CLO97 also produced higher levels of TNFa, IFNc, IL-1b, IL-6,
IL-1RA, CCL7, and CXCL10 (Fig. 5B). Peripheral blood mononuclear cells
from adults stimulated with LPS produced higher levels of TNFa, IL-1a,
and IL-1b (Fig. 5C) and, when stimulated with 50-pppRNA/Lyovec,
produced higher levels of CCL7 (Fig. 5D). CCL1 was the only measured
inflammatory mediator that was higher in the supernatants in response
to LPS and CL097 in old subjects at 24 h (Fig. 5-C). This result
corroborated the unique induction pattern of the CCL1 transcript in
old subjects following stimulation with LPS and CLO97 (Fig. 1B).
Notably, we found similarity between mRNA and protein levels for
some genes including IFNc and CCL7, whereas others genes such as
CCL2, TNFa, and IL-1b which was altered by aging at the protein levels
were found to be unchanged at the transcript levels. This could arise
from the kinetics of expression or biological factors, such as mRNA
degradation. Overall, the delayed transcriptional response by PBMCs
from old individuals was accompanied by a decreased production of pro-
inflammatory cytokines and chemokines.
PBMCs from adults stimulated higher levels of T-cell
proliferation in response to PRR agonists
To assess whether the cross talk between innate and adaptive immunity
was impaired in old adults, we performed an allogeneic mixed lymphocyte
reaction (MLR) using agonist-stimulated PBMCs (minus CD3 T cells) from
adults and old donors (n = 10/group) cultured with pooled CFSE-labeled
CD3+ T cells from adults (n = 2) (Fig. 6). At day 3 (D3) of coculture, in the
absence of TLR stimulation, the percentage of adult donors that elicited T-
cell proliferation was higher (although not significant) compared to old
donors (30% vs. 10%) (Fig. 6A). Pre-incubation of adult PBMCs (minus
CD3 T cells) with PRR agonists further enhanced the proliferation of T cells
with CLO97 inducing 70% of adults vs. 20% of old subjects (P < 0.05),
whereas LPS induced 60% of adults vs. 10% of old subjects (P < 0.05). At





Fig. 5 PBMCs from adults produced
higher levels of inflammatory cytokines,
IFNs, and chemokines in response to PRR
agonists. (A) Graphs depict the
means  SEM of IFNa, TNFa, and CCL2
concentrations in response to stimulation
with CLO97 and LPS for 6 and 24 h for
adult and old subjects. TNFa and CCL2
were measured by CBA, whereas IFNa was
measured by ELISA. (B-D) Table depicts the
means  SEM for cytokines and
chemokines measured by Milliplex that
showed age-related alternations after
stimulation with (B) CLO97, (C) LPS, and (D)
50-pppRNA/Lyovec for 24 h. Asterisks
indicate statistical significance (***)
P < 0.001, (**) P < 0.01, and (*) P < 0.05)
between treated PBMCs vs. negative
controls and adult vs. old subjects using
two-way ANOVA followed by Sidak
correction for multiple comparisons. n = 8/
group.
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higher T-cell proliferation (P < 0.01 and P < 0.05, respectively) (Fig. 6B).
These results demonstrate that aging alters the ability of innate immune
cells to activate T cells, which could contribute to the dysfunctional
adaptive immune responses observed in the elderly.
Discussion
We used a global approach to study the early and late effects of a broad
range of innate immune agonists on PBMCs isolated from adult and old
individuals. A major finding of this study is that PBMCs from old subjects
exhibited a slower immune response to PRR agonists compared to cells
from adult individuals. This was evident by the rapid induction of the
interferon signaling pathway in PBMCs from adults treated with LPS,
CLO97, and 50-pppRNA/Lyovec, as well as secretion of IFNa and IFNc in
response to CLO97. Our results support other studies that showed
interferon production is impaired in PBMCs from elderly subjects
stimulated in vitro with endotoxin or virus antigens (Abb et al., 1984;
Ouyang et al., 2000). Type I IFN (IFNa/b) and type II IFN (IFNc) induce
antiviral activity and cell-mediated immunity, respectively, and regulate
the differentiation of effector T-cell subsets and activation of B cells
leading to a robust Ag-specific immune response (Jego et al., 2003;
Commins et al., 2010). Thus, age-dependent delays in IFN signaling
could contribute to heightened susceptibility to viral infections within the
elderly population, such as neuro-invasive WNV (Samuel & Diamond,
2005).
This delayed interferon response also was associated with reduced
production of pro- and anti-inflammatory cytokines and chemokines
including TNFa, CCL2 IL-1b, IL-6, IL-1RA, CCL7, and CXCL10; however,
old subjects did produce higher levels of CCL1 in response to LPS and
CLO97. In vitro studies aimed at examining cytokine production in aging
population have yielded inconsistent results. For example, it has been
reported that DCs and monocytes obtained from old subjects produced
more cytokines than those form adults (Alvarez-Rodriguez et al., 2012;
Hearps et al., 2012). On the other hand, others have reported no change
or lower production in old compared to adult subjects (Gon et al., 1996;
van Duin et al., 2007b; Panda et al., 2010). In the case of PBMCs,
studies have yielded increased production of cytokines and chemokines
[including CCL3, CCL5, IL-6, TNFa, and IL-1b (Fagiolo et al., 1993;
Pulsatelli et al., 2000)] in the elderly population, which is contrasting to
our results. A contributing factor for these conflicting studies could be
the use of different stimuli or method of preparation of the same
stimulus, which can influence the immune response and level of cytokine
produced. A low-grade chronic pro-inflammatory status is associated
with aging (termed ‘inflamm-aging’), which appears to be more
associated with comorbidities (such as frailty) and not healthy normal
aging (Franceschi et al., 2007). Thus, different enrollment criteria
(including definition of frailty) used by various studies could also explain
these conflicting results. Using nonfrail subjects, our work provides
further evidence for cytokine dysregulation during normal aging.
We observed the enrichment of functional pathways (including the
communication between innate and adaptive immune cells, roles of
cytokines in mediating communication between immune cells, cross talk
between DCs and NK cells, and interferon signaling) in young subjects
that suggest both innate and adaptive immunity are altered by aging in
old subjects. In our study, it is difficult to show the contribution of
individual immune subsets to the overall impairment observed in old
subjects; however, at the transcriptional level, monocyte signal was more
enriched in adults for up to 24 h in response to LPS, poly I:C/Lyovec, and
50-pppRNA/Lyovec, as well as T-cell signal induced by LPS up to 24 h and
poly I:C at 6 h and B cells induced by CLO97 and 50-pppRNA at 24 h.
The delayed and blunted levels of interferons, cytokines, and chemo-
kines produced in old individuals could have been caused by the direct or
indirect activation of both innate and adaptive immune cells. In fact, age-
related decrease in IFNc and TNFa-positive CD4+ T cells has been
observed in old subjects after activation (Alberti et al., 2006). Therefore,
it is possible that the immune response defects observed in old subjects
are global and involved all arms of the immune response.
Monocytes and dendritic cells are first line of defense against invading
pathogens and play a pivotal role in immune regulation by producing
cytokines including IL-1a/b, IL-6, IL-8, and TNFa and presenting antigens
to T cells. At the transcriptional level, we observed the signal for
monocytes and pDCs enriched in adults and old subjects, respectively,
but it is also difficult in our study to know the contributions of monocyte
and DC subsets in the overall age-associated changes. Although aging
can cause a shift in human monocyte and dendritic cell subsets (Jing
et al., 2009; Seidler et al., 2010), as well as reduced TLR expression
(Kong et al., 2008; Shaw et al., 2011; Qian et al., 2012), we observed
unaltered proportions of monocytes and dendritic cells and no differ-
ences in TLR surface and intracellular expression on monocytes. Our
work suggests the impairment of downstream signaling events in
monocytes and dendritic cells from old donors.
(A)
(B)
Fig. 6 PBMCs from adults induced higher levels of proliferation of allogeneic T cells.
Allogeneicmixed lymphocyte reaction (MLR) using LPS- or CLO97-stimulated PBMCs
(minus CD3 T cells) from adults and old donors (n = 10/group) cultured with pooled
CFSE-labeled CD3+ T cells from adults (n = 2). Graphs depict the frequency of
dividing CD3 T cells (CFSE low) after day 3 (D3) (A) and day 5 (D5) (B) of culturing.
Individual values along with mean are shown. Frequencies > 1 (baseline) were
considered significant, indicating a gating of > 20 events. For D3, the percentage of
donors above baseline (dash line) is listed in table below graph. Statistical significance
between adults and old subjects was determined by Mann–Whitney U-test.
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Lymphocyte interaction with co-stimulatory (e.g., CD80, CD86, and
CD40) and negative regulatory molecules (e.g., PD-L1, PD-L2, and B7-H4)
expressed on activated innate immune cells, as well as stimulation by
cytokines and chemokines, is necessary for the differentiation into effector
subsets. Co-stimulatory and negative regulatory molecules are regulated
by inflammatory cytokines, including type I IFN and type II IFN (Freeman
et al., 2000; Zhu et al., 2012). The impaired cytokine signaling observed in
old PBMCs could differentially affect expression of these regulatory
molecules between adult and old individuals. Indeed, we observed age-
related alternations in the upregulation of PD-L1 on T cells andmonocytes
and PD-L2 and B7-H4 on B cells in response to CLO97 after 24 h. We
observed old individuals had reduced frequency of CD40+monocytes and
B cells compared to adults under nonactivated conditions. Previously, the
percentage of CD40+ B cells was shown to be unaltered with aging
(Colonna-Romano et al., 2003). These contrasting results could arise from
the use of different culturing conditions (fresh blood verse frozen PBMCs)
and different cohorts. More insight will be gained by analyzing CD40
expression on agonist-stimulated cells mimicking a pathogen response.
Indeed, analyses of TLR-induced upregulation of co-stimulatory proteins
on monocyte revealed age-associated defects in co-stimulatory CD80
expression but not CD86 (van Duin et al., 2007a).
The observed age-related alternations in cytokine and chemokine
production, as well as expression of co-stimulatory and inhibitory
molecules, lead us to hypothesize that the interface between the innate
and adaptive immune responses is impaired in the elderly, which might
explain the increased susceptibility to infectious diseases and poor
responses to vaccination. We observed that agonist-stimulated PBMCs
(minus CD3 T cells) from old subjects induced lower proliferation of
allogeneic adult T cells compared to stimulatedPBMCs fromadult subjects,
suggesting the ability of innate immune cells (including monocytes and
DCs) to activate T cells is altered with aging. These results were supported
by other studies which showed proliferative responses of T cells from
elderly subjects were significantly reduced when mixed with non-T cells
from adults (Molteni et al., 1994; You et al., 2013).
In summary, our results provide a comprehensive analysis of the
signaling of multiple PRRs in PBMCs in the context of aging. Peripheral
blood mononuclear cells from old subjects were less responsive to innate
immune agonists and generated responses of altered quality and quantity.
These age-related changes in the cytokine milieu and co-stimulatory
molecule expression have the potential to impair the cross talk between
the innate and adaptive immunity, which might explain the increased
susceptibility to infectious diseases and poor responses to vaccination. Our
agonist-induced functional profiles provide a basis for identifying and
studying distinct genes and mechanisms important in PRR signaling. This
should foster the design of new approaches to improve vaccine efficacy
and antipathogen responses in the elderly population.
Experimental procedures
Ethic statement
This study was approved by the Institutional Review Board of the
University of Arizona (Tucson, AZ) and Martin Health System (Stuart, FL,
USA). All participants in this study were > 21 years of age. Written
informed consent was obtained from all subjects.
Patient recruitment and PBMC isolation
Healthy community-dwelling subjects were enrolled from University of
Arizona and Martin Health system (Florida) in two groups: adults (21–
40 years,n = 31) andnonfrail old individuals (65–93 years,n = 31).Using
a screening questionnaire, participants were asked about lifestyle, clinical
history, and medication usage. Subjects were excluded that self-reported
comorbid conditions including cancer (within the last 5 years for those
≥ 65 years), immunocompromising disorders, and steroid usage,whereas
inclusion criteria included controlled hypertension, occasional/tolerable
‘aching joints’ from arthritis, and not taking daily NSAIDS or acetamino-
phen, and controlled diabetes. Our definition of nonfrail subjects was
based on Fried criteria (Bouillon et al., 2013). The Katz index of
independence in activities of daily living (ADL) was used to assess the
functional impairment of subjects≥ 65 years (Katz et al., 1970). The index
ranks adequacy of performance in bathing, dressing, toileting, transfer-
ring, continence, and feeding. Subjects with a score lower than 6
(indicatingmoderate to severe impairment) were excluded from the study.
Old subjects were also assessed for dementia using the Mini-COG
assessment instrument for dementia (Borson et al., 2003). The Mini-Cog
combines two simple cognitive tasks [three-item word memory and clock
drawing test (CDT)]with anempirical algorithmfor scoring. Subjectswith a
recall score of 1–2wordswith a normalCDTor a recall score of threewords
were considered nondemented. Demographic data for the cohort used in
this study are described in Table S7. The description of subjects used for
gene array, cytokine analysis, and surface phenotypic analysis is provided
in Table 1 (n = 8/group). For some surface phenotypic analysis and MLR
analysis, additional subjects were selected from the cohort. Blood was
drawn into heparinized Vacutainer CPT tubes (BD Bioscience, Franklin
Lakes, NJ, USA) and processed as permanufacturer’s recommendations to
isolate peripheral blood mononuclear cells (PBMC) and plasma; Li-EDTA
tubes were used to determine complete blood counts. Peripheral blood
mononuclear cellswere also isolated from leukapheresis using Ficoll-Paque
(GE Healthcare, NJ, USA) density gradient media. Peripheral blood
mononuclear cells were frozen in 90% FBS and 10% DMSO.
In vitro stimulation of PBMCs
Total PBMCs isolated from adults and old subjects were plated in
triplicate at 100 000 cells/well in 96-well U-bottom plates. Cells were
suspended in cultured RPMI medium [RPMI with L-glutamine (Corning
Cellgro, Manassas, VA, USA) supplemented with 10% FBS and 19 (50U)
penicillin–streptomycin (Life Technologies, Carlsbad, CA, USA)]. TLR and
RIG-I agonists were added at the following concentrations: LPS-TLR4
(0.5 lg mL1) or CLO97-TLR7/8 (0.5 lg mL1) or poly I:C/Lyovec-RIGI/
MDA5 (2 lg mL1) or 50-pppRNA/Lyovec-RIG-I (400 ng mL1). Optimal
concentrations of different TLR agonists were selected based on median
production of IL-6 and IFN-a and a ≥ 85% survival rate of PBMCs. All
PRR ligands were purchased commercially (InvivoGen, San Diego, CA,
USA) except for 50-pppRNA, which was custom synthesized, as previ-
ously described missing reference (Goulet, ML et al, 2013). Peripheral
blood mononuclear cells cultured in medium alone were used as a
control for LPS and CLO97. Stimulation by poly I:C and 50-pppRNA
required the use of a cationic transfection agent LyoVec (InvivoGen), so
medium plus Lyovec alone was used as a control for these two agonists.
Peripheral blood mononuclear cells were cultured for 6 and 24 h at
37 °C in a 5% CO2-humidified environment.
Microarray and bioinformatics analyses
Cells were washed twice with cold PBS and lysed with 100 ll of cold
RLT buffer (QIAGEN, Frederick, MD, USA) supplemented with 1% beta-
mercaptoethanol (BM) (Sigma, St. Louis, MO, USA) and transferred to
1.7-mL tubes with 250 lL of cold RLT/BM buffer and quickly stored at
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80 °C. RNA was isolated using a Qiagen’s RNeasy Micro Kit followed
by DNase I treatment. Quantification was performed using a NanoDrop
spectrophotometer (Thermo Scientific, Wilmington, DE, USA), and RNA
quality was assessed using Experion automated electrophoresis system
(Bio-Rad, Hercules, CA, USA) with a HeLa RNA-positive control and
nontemplate negative control. RNA was converted into biotinylated
cRNA using the Illumina Total Prep-96 RNA amplification kit (Life
Technologies). Biotinylated cRNA was normalized and hybridized to the
Illumina Human HT-12V4 Expression BeadChips according to the
manufacturer’s instruction and quantified using an Illumina iScan System
(illumina, San Diego, CA, USA). The data were collected using ILLUMINA
GENOMESTUDIO software. Analysis of the microarray output data was
conducted using the R statistical language (R Core Team, 2010) and the
LIMMA and Combat (batch correction) statistical packages from
Bioconductor (Gentleman et al., 2004). Microarrays displaying unusually
low median intensity, low variability, or low correlation relative to the
bulk of the arrays were discarded from the rest of the analysis. Quantile
normalization, followed by a log2 transformation using the LIMMA
package, was applied to process microarrays. Subsequently, the LIMMA
package was used to fit a linear model to each probe and to perform a
(moderated) Student’s t-test on various differences of interest (Smyth
et al., 2005). In addition, the LIMMA package from Bioconductor was
used to identify differentially expressed genes (DEGs) between treated
vs. controls (untreated or Lyovec only) or adult vs. old PBMCs. For data
mining and functional analyses, DEGs satisfied a stringent false discovery
rate (FDR) of 5% with ≥ 1.3 or ≤ 1.3 fold change (FC). Probes that did
not map to annotated RefSeq genes and control probes were removed.
The expected proportions of false positives (FDR 5%) were estimated
from the unadjusted P value using the Benjamini and Hochberg method
(Benjamini & Hochberg, 1995). An innate gene filter derived from Gene
Ontology (GO) was used to highlight innate immunity-related genes
within the datasets. The filter was based on innate immune response
query (GO: 0045087). All network analysis was performed with
ingenuity pathway analysis (IPA: Ingenuity systems). Illumina Probe IDs
were imported into IPA and mapped to the gene symbol. Differentially
expressed genes (selected based on a nominal P value ≤ 0.05 and FC
≥  1.3) that were associated with a canonical pathway in Ingenuity’s
Knowledge Base were used for pathway analysis. The significance of the
association between the dataset and the canonical pathway was
measured in two ways: (i) A ratio of the number of genes from the
dataset that map to the pathway divided by the total number of genes
that map to the canonical pathway was displayed, and (ii) over-
representation of Fisher’s exact test was used to calculate a P value
determining the probability that the association between the genes in
the dataset and the canonical pathway was explained by chance alone.
The pathways were ranked by log P value. Microarray data are
available at the NCBI GENE Expression Omnibus (GSE62627).
Flow cytometry analysis
PBMCs were stained for monocyte subsets using the following cocktail
panel: CD19 PE Cy7, CD3 APC Cy7, CD16 AF700, and CD14 PerCp.
Dendritic cells were pre-enriched from PBMCs using a pan-DC enrichment
kit from Stem Cell Technologies (Vancouver, DC, Canada). DC subsets
were stainedusing the following cocktail panel: CD3PECy5, CD19 PECy7,
HLA-DR AF700, CD11c PB, CD1c APC Cy7, CD141 FITC, and CD303 APC.
Absolute numbers of cell subsets for each subject were determined by
dividing individual subset frequencies by total lymphocyte (for monocytes
subsets) or white blood cell (for DC subsets) count obtained from Coulter
counter (Beckman Coulter, Pasadena, CA, USA). For surface phenotypic
analysis, PBMCswere culturedwith orwithoutCLO97 for 24 h and stained
with CD3 APC-Cy7, CD19 PE Cy7, CD14 PerCp, CD16 AF700, and CD11c
PB with one of the following molecules: TLR3 PE, TLR4 PE, TLR7 PE, CD40
PE,CTLAPE, PD-L1 PE, PD-L2 PE, B7-H4PE,or ICOSLPE.All antibodieswere
obtained fromBiolegend, except forCD3-APCCy7 (BDBioscience, Franklin
Lakes, NJ, USA), TLR7 PE, and CD14 PerCP (R&D Systems, Minneapolis,
MN, USA), CD3 PECy5 (Affymetrix eBioscience, San Diego, CA, USA), and
CD141 FITC and CD303 APC (Miltenyi, San Diego, CA, USA). Dead cells
were identified using LIVE/DEAD Fixable Aqua Dead Cell Stain Kit for flow
cytometry (Life Technologies). Cells were evaluated on a BD LSR II flow
cytometer, and frequencies were gated using BD DIVA software.
Cytokine and chemokine analysis
Supernatants collected from stimulated PBMCs at 6 and 24 h were
analyzed for Th1/Th2/Th17 cytokines (IL-2, IL-4, IL-6, IL-10, TNF, IFN-c, and
IL-17A) and chemokines (CCL2,CCL5,CXCL8,CXCL9, andCXCL10) using
BDhumancytometric beadarray kits (CBA) (BDBiosciences). Sampleswere
acquired on a BD FACSArray and analyzed using FCAP ARRAY software (BD
Biosciences). IFN-a production at 6 and 24 hwasmeasured using an IFN-a
ELISA (PBL Interferon Source). Supernatants collected at 24 h were also
analyzed using Milliplex MAP magnetic bead assays (Millipore, Billerica,
MA, USA). Two human Milliplex premixed panels were used. Panel 1 38-
plex: EGF, eotaxin (CCL11), FGF-2, Flt-3 ligand, fractalkine (CX3CL1), G-
CSF, GM-CSF, GRO (CXCL1), IFN-a2, IFN-c, IL-10, IL-12 (p40), IL-12 (p70),
IL-13, IL-15, IL-17, IL-1ra, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-
9, IP-10 (CXCL10), MCP-1 (CCL2), MCP-3 (CCL7), MDC (CCL22), MIP-1a
(CCL3), MIP-1b (CCL4), TGFa, TNF-a, TNF-b, VEGF, and sCD40L. Panel 2
23-plex: (CCL21) 6Ckine, BCA-1 (CXCL13), CTACK (CCL27), ENA-78
(CXCL5), eotaxin-2 (CCL24), eotaxin-3 (CCL26), I-309 (CCL1), IL-16, IL-20,
IL-21, IL-23, IL-28A, IL-33, LIF, MCP-2 (CCL8), MCP-4 (CCL13), MIP-1d
(CCL15), SCF, SDF-1A+b (CXCL12), TARC (CCL17), TPO, TRAIL, and TSLP.
The manufacturer’s protocol was followed. Data were acquired on a Bio-
Plex 200 System (using bead regions defined in the Milliplex protocol) and
analyzed with the BIO-PLEX MANAGER 6.1 software from Bio-Rad.
Allogeneic mixed lymphocyte reaction
CD3 T cells were isolated from total PBMCs obtained from healthy adult
subjects (pooled two subjects) by negative isolation using a human T-cell
enrichment kit (Stem cell). Prior to CD3 enrichment, PBMCs were labeled
with carboxyfluorescein diacetate succinimidyl ester (CFSE; Life Technol-
ogies) for subsequent assessment of T-cell proliferation. For agonist-
stimulated PBMCs, CD3 T cells were removed from PBMCs by positive
selection using a human T-cell enrichment kit (Stem cells). Harvested
PBMCs (minus CD3 T cells) were adjusted to a concentration of 2x106
cells mL1 with cultured RPMI medium and cultured with 0.1 lg mL1
LPS or 1 lg mL1 CLO97 or without stimuli in a 37 °C, 5% CO2
atmosphere for 20 hrs. Agonist-stimulated PBMCs (minus CD3 T cells)
from adult and old subjects were washed three times with cultured RPMI
medium and co-incubated 1:1 with T cells from young subjects in a 37 °C,
5% CO2 atmosphere for 5 days. For the gating of CFSE
lowCD3+ T cells,
frequencies with a gating of > 20 events were considered significant.
Peripheral blood mononuclear cells used for these experiments were
obtained from leukapheresis of healthy adult and old subjects.
Statistical methods
For DC/monocyte, TLR, CD40, and MLR analysis, P values were
determined by two-sided nonparametric Mann–Whitney U-test, which
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ranks the data rather than their raw values to calculate the statistical
significance and is an alternative to the t-test, when the assumption of
normality is not satisfied or could not be tested in the case of small
sample sizes. For cytokine production and surface receptor upregulation
analysis, significant differences between multiple comparisons (LPS or
CLO97-treated vs. untreated PBMCs, poly I:C/Lyovec or 50-pppRNA/
Lyovec-treated vs. Lyovec-only treated PBMCs, and adult vs. old PBMCs)
were determined by two-way ANOVA test followed by Sidak correction
for multiple comparisons. A P value < 0.05 was considered significant.
Data were analyzed and figures generated using GRAPHPAD PRISM 6
software (GRAPHPAD software, La Jolla, CA, USA).
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Fig. S1 Absolute number and frequency ofmonocyte and dendritic cell subsets
is unchanged with age. Representative dot plots depicting the gating scheme
for (A) CD14dimCD16+,CD14+CD16+ andCD14+CD16monocyte subsets and
(B) mDC1 (CD11c+CD1c+CD141CD303), pDCs (CD11cCD1c
CD141CD303+) and mDC2 (CD11cloCD1cCD141+CD303) DC subsets.
Graphs depict the absolute numbers and frequencies for monocytes (C and E)
andDCs (D and F). Individual values alongwithmean  SEMare shown (n = 8/
group except for mDC2% n = 5/group). Adults were compared to old subjects
byMann-WhitneyU test; and P values are given if the differences are statistically
significant.
Fig. S2 Expression of TLR3, TLR4 and TLR9 on monocytes was unchanged with
age. Peripheral blood mononuclear cells isolated from adult and old subjects
were stained for CD14dimCD16+, CD14+CD16+ and CD14+CD16 monocyte
subsets and either TLR 3 PE, TLR 4 PE or TLR 7 PE. Frequency values along with
mean  SEM are shown (n = 7/group). Adults were compared to old subjects
byMann-WhitneyU test; and P values are given if the differences are statistically
significant.
Fig. S3 Frequency of CD40+ B cells was reduced in PBMCs from old subjects
compared to adults. Peripheral bloodmononuclear cells isolated fromadult and
old subjects were stained for CD19+ CD40+ B cells. Frequencies (within total B
cells) alongwithmean  SEMare shown (n = 6/group).Adultswere compared
to old subjects by Mann-Whitney U test.
Table S1 Transcriptional profiles for agonist-treated PBMCs from adults
compared to negative controls. The table lists DEGs resulting from contrasting
agonist-stimulated PBMCs from adults (n = 8) to negative controls. Differen-
tially expressed geneswere selected based on FC ≥ 1.3 or ≤ 1.3 and FDR 5%.
For poly I:C/Lyovec 6 h, genes were selected based on nominal P value < 0.05
and FC ≥ 1.3 or ≤ 1.3 due to FDR 5% resulting in zero genes.
Table S2 Transcriptional profiles for agonist-treated PBMCs from old subjects
compared to negative controls. The table lists DEGs resulting from contrasting
agonist-stimulated PBMCs from old subjects (n = 8) to negative controls.
Differentially expressed genes were selected based on FC ≥ 1.3 or ≤ 1.3 and
FDR 5%. For poly I:C/Lyovec 6 h, genes were selected based on nominal P
value < 0.05 and FC ≥ 1.3 or ≤ 1.3 due to FDR 5% resulting in zero genes.
TableS3Venndiagramanalysis contrasting adult to old PBMCs stimulatedwith
PRR agonists. The table lists unique and common DEGs resulting from Venn
diagram analysis comparing cells from adult and old subjects (n = 8/group)
stimulated with agonists (both age groups normalized to their respective
negative controls). Differentially expressed genes were selected based on FC
≥ 1.3 or ≤ 1.3 and FDR 5%.
Table S4 IPA pathway analysis contrasting stimulated to negative control
PBMCs. Table lists P values, pathway enrichment scores, and enriched
molecules resulting from IPA pathway analysis contrasting stimulated to
untreated (LPS and CLO97) or Lyovec only (50-pppRNA/Lyovec and poly I:C/
Lyovec) PBMCs for adult and old individuals (n = 8/group).
TableS5Specific cell typemeta analysis contrasting adults to old subjects. Table
lists normalized enrichment scores (NES), P values, and enriched molecules
resulting from specific cell-type meta analysis contrasting adults to old subjects
(n = 8/group) stimulatedwith agonists. Positive (+) NES represent upregulation
in adults, whereas a negative () NES represent upregulation in old subjects.
Table S6 Concentrations (pg mL1) of cytokines and chemokines induced by
agonists stimulation of PBMCs. Table lists cytokine and chemokine concentra-
tions (mean  SEM) elicited by no treatment, LPS, CLO97, and Lyovec-treated
only, 50-pppRNA/Lyovec, and poly I:C/Lyovec (n = 8/group). 6 h concentration
levels measured by ELISA and CBA, whereas 24 h levels measured by Milliplex
bead assays. Assay sensitivities listed in table were taken from the manufac-
turer’s manual (LOD = below limited of detection). Statistical significance
between untreated vs. treated and adult vs. old subjects was determined by
two-way ANOVA followed by Sidak correction for multiple comparisons. (*)
P < 0.05, (**) P < 0.01, (***) P < 0.00, and (****) P < 0.0001.
Table S7 Description of adult and old cohorts. Table depicts total number of
subjects used in this study.
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